Current Journal of Neurology, published by Tehran University of Medical Sciences, is an esteemed Open Access journal dedicated to advancing the field of neurology. Since its inception in 2011, the journal has provided a platform for innovative research and critical discourse in neurology and clinical neurology, with a focus on the latest advancements and methodologies. Although the journal currently holds a Q4 quartile ranking in both neurology and clinical neurology, its goal is to foster the global dissemination of knowledge and ideas relevant to the complexities of neurological disorders. Researchers, professionals, and students exploring this dynamic field will find valuable insights, as the journal aims to bridge the gap between emerging research and clinical application. Based in Tehran, Iran, the Current Journal of Neurology welcomes contributions that enhance understanding and treatment of neurological conditions, thereby promoting evidence-based practices across the globe.

Clinical Neurophysiology Practice, published by Elsevier, is an esteemed open-access journal focusing on innovative research and clinical practices in the field of neurophysiology. Since its inception in 2016, this journal has been dedicated to advancing the understanding of neurological disorders through cutting-edge studies and practical applications, making it a vital resource for researchers, clinicians, and students alike. With an ISSN of 2467-981X, it operates from the Netherlands and has established itself with a commendable position in various medical and neurological categories, as evidenced by its Q3 ranking in Neurology, Clinical Neurology, and Medical Physiology for 2023. The journal encourages the dissemination of rigorous scientific research while providing immediate access to its content, making it an attractive option for those seeking to enhance their knowledge and contribute to the field. As it continues to bridge research with clinical application, Clinical Neurophysiology Practice stands as a pivotal platform that fosters a deeper understanding of neurophysiological mechanisms and their clinical implications.

CLINICAL EEG AND NEUROSCIENCE, published by SAGE Publications Inc, stands as a pivotal journal in the fields of neurology and neuroscience, with a focus on the latest research and advancements in clinical electroencephalography and neurophysiology. Since its inception in 1970, the journal has provided a platform for rigorous scholarly work, offering valuable insights into neurological disorders and EEG technology. With its current categorization in the Q2 and Q3 quartiles across various subfields of medicine and neurology, it ranks prominently in the Scopus database, emphasizing its significance in academic discourse. The journal's commitment to disseminating high-quality research is underscored by its open access options, facilitating broader accessibility to its published findings. For researchers, clinicians, and students alike, CLINICAL EEG AND NEUROSCIENCE remains an essential resource for keeping abreast of the evolving landscape of neurological studies.

The Revista Mexicana de Neurociencia, published by the ACAD MEXICANA NEUROLOGIA, serves as a pivotal platform for the dissemination of research within the field of neurology and neuroscience. Although it was active from 2008 to 2014 and is no longer covered in Scopus, the journal still holds a significant place in the academic community, addressing critical topics relevant to both clinical and experimental neurology. With an emphasis on advancing knowledge in neuropsychology and public health, this journal targets researchers, professionals, and students alike, fostering an interdisciplinary dialogue that can enhance the understanding of neurological conditions within Mexico and beyond. As it stands, the journal is not open access, which may present challenges for accessibility, yet its affiliation with recognized academic standards underlines its commitment to quality research. This platform once provided insights that can inform practice and stimulate innovative approaches in the management of neurological disorders, underscoring its importance in the evolving landscape of neuroscience.

NEURO-OPHTHALMOLOGY is a distinguished journal published by Taylor & Francis AS, focused on the intersection of neurology and ophthalmology. With an ISSN of 0165-8107 and an E-ISSN of 1744-506X, this journal has been a vital resource for both clinicians and researchers since its establishment in 1980, covering pivotal studies and advancements in the neuro-ophthalmic field until 2024. Classified as Q3 in both the Neurology (clinical) and Ophthalmology categories for 2023, NEURO-OPHTHALMOLOGY strives to publish high-quality research that enhances our understanding of neuro-ophthalmic conditions and their management. Despite not being an open-access journal, it remains an essential platform for disseminating significant findings, contributing to the global research community engaged in the evolving realms of vision and neurological health. The journal is indexed in Scopus, illustrating its relevance and accessibility to professionals seeking evidence-based insights and fostering innovation in clinical practices.

CURRENT OPINION IN NEUROLOGY is a premier academic journal dedicated to providing insightful overviews and critical analyses across all areas of neurology and clinical neurology. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an impressive impact factor, highlighting its influence and relevance in the field—positioning it in the Q1 category for both neurology and clinical neurology as of 2023. With its comprehensive coverage, the journal serves as a vital resource for researchers, healthcare professionals, and students aiming to stay abreast of the latest developments, trends, and breakthroughs in neurological science and practice. Though not open access, articles are available via institutional subscriptions or individual purchase, ensuring that vital research remains accessible to a wide audience. Covering research from its inception in 1993 to ongoing studies in 2024, CURRENT OPINION IN NEUROLOGY stands out as an essential platform for disseminating knowledge and fostering dialogue within the dynamic and evolving landscape of neurology.

Epilepsi is an esteemed academic journal dedicated to advancing the field of epilepsy research and treatment, published by KARE PUBL. With its open access model established since 2017, the journal ensures that vital research findings are easily accessible to a global audience, thereby fostering collaboration and knowledge sharing among researchers, healthcare professionals, and students. The journal focuses on a comprehensive range of topics within neurology, including clinical studies, therapeutic advancements, and innovative approaches to epilepsy management. Located in Istanbul, Turkey, Epilepsi aims to bridge the gap between research and practice, enhancing understanding and patient care for individuals affected by epilepsy. Its commitment to high-quality, peer-reviewed content makes it a significant resource for anyone involved in epilepsy research or clinical practice.

NEUROPATHOLOGY, an esteemed journal published by WILEY, is a pivotal platform in the fields of medicine and neurology, focusing on the intricate relationship between pathology and neurological disorders. Established in 1993 and continually evolving until 2024, the journal holds a notable presence within the academic community, as evidenced by its current Q2 ranking in several categories including Medicine (Miscellaneous), Neurology (Clinical), and Pathology and Forensic Medicine. With a Scopus ranking placing it within the top 30% of its field, NEUROPATHOLOGY serves as a vital resource for researchers, healthcare professionals, and students dedicated to advancing their knowledge of neuropathological processes. Although not an Open Access journal, it ensures accessibility to cutting-edge research and insights that shape contemporary understanding and clinical practice. Its robust impact factor underscores the journal's critical role in disseminating innovative findings within the realms of neurology and pathology, making it an essential read for those at the forefront of medical research.

Degenerative Neurological and Neuromuscular Disease is a distinguished academic journal published by DOVE MEDICAL PRESS LTD, focusing on the latest advancements in the field of neurology and neuromuscular disorders. With a commitment to disseminating high-quality research, the journal aims to provide a critical platform for researchers, healthcare professionals, and students to share and engage with groundbreaking studies that advance our understanding of degenerative conditions affecting the nervous system. Although the journal's impact factor and h-index are currently not available, its open access model ensures that the valuable findings published within are accessible to a global audience, thereby fostering collaboration and innovation in neurological health. The journal's address is PO BOX 300-008, Albany, Auckland 0752, New Zealand, reflecting its international relevance and commitment to advancing the field of neurology. As the understanding of neurodegenerative diseases and neuromuscular challenges continues to evolve, Degenerative Neurological and Neuromuscular Disease serves as an essential resource for anyone dedicated to improving patient outcomes and advancing scientific knowledge.

Journal of Endometriosis and Pelvic Pain Disorders, published by SAGE Publications Ltd, is a vital resource dedicated to advancing the understanding and management of endometriosis and associated pelvic pain disorders. With an ISSN of 2284-0265 and E-ISSN 2284-0273, this journal caters to a diverse audience of researchers, healthcare professionals, and students in the field of Obstetrics and Gynecology. It has a notable 2023 Scopus ranking of #139 out of 209 in its category, positioning it within the Q3 quartile based on its impact and contribution to the literature. The journal aims to publish cutting-edge research, reviews, and clinical guidelines that illuminate the complexities of endometriosis and enhance patient care. Available through various academic channels, it not only fosters scholarly discourse but also supports the academic community in addressing the challenges and advancements in the treatment of pelvic pain disorders. As the journal approaches its converged years from 2013 to 2024, it stands as a critical platform for disseminating impactful findings in a field that significantly affects women’s health globally.